In BRCA1/BRCA2 testing of over 12,000 unrelated women with breast and/or ovarian cancer in France, Golmard et al. [9] identified four women with de novo variants, including a mosaic BRCA1 variant in a woman with breast cancer diagnosed at age 41 years [9]. The gene discussed is BRCA1; the disease is ovarian carcinoma.